Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Statistics & Valuation Metrics

Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $2.28M. The enterprise value is $1.68M.

Shuttle Pharmaceuticals Holdings, Inc. has 637,108 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -5.20 and return on invested capital (ROIC) is -460.77%.

The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is ―. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is 0.00253.

In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -11.72M in profits. Earnings per share was -71.60.

In the last 12 months, operating cash flow was -9.37M and capital expenditures 4.00, giving a free cash flow of -9.37M billion.

Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is Sep 4, 2024, Before Open (Confirmed).

Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 0.06, with Debt / Equity ratio of 6.40%

In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.

Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is -0.25, with an EV/FCF ratio of -0.30.

Shuttle Pharmaceuticals Holdings, Inc. has $1.09M in cash and marketable securities with $214.01K in debt, giving a net cash position of $875.93K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―